Research / BRZE / Fundamental state Inspectable configuration
State dimensions Filing 0001676238-23-000031 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.35% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-6.28% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
49.32% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
67.41% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-41.68% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
27.37% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
20.33% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Oct 31, 2021 0/4 normalized Level 3 Jan 31, 2022 0/6 normalized Level 3 Apr 30, 2022 0/6 normalized Level 3 Jul 31, 2022 0/6 normalized Level 3 Oct 31, 2022 0/7 normalized Level 3 Jan 31, 2023 0/7 normalized Level 3 Apr 30, 2023 0/7 normalized Level 3 Jul 31, 2023 0/7 normalized Level 3 Oct 31, 2023 4/7 normalized Level 3 Jan 31, 2024 6/7 normalized Level 3 Apr 30, 2024 6/7 normalized Level 3 Jul 31, 2024 6/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 4.53%
Current 4.35%
Delta -0.19% Cash Generation Increased
Previous -25.69%
Current -6.28%
Delta 19.41% Growth Increased
Previous 45.58%
Current 49.32%
Delta 3.74% Margin Decreased
Previous 68.71%
Current 67.41%
Delta -1.30% Profitability Decreased
Previous -39.59%
Current -41.68%
Delta -2.09% R And D Intensity Decreased
Previous 27.47%
Current 27.37%
Delta -0.10% Sbc Intensity Decreased
Previous 20.73%
Current 20.33%
Delta -0.41% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.